Recent Research Analysts’ Ratings Updates for Eli Lilly and Company (LLY)
Eli Lilly and Company (NYSE: LLY) has recently received a number of price target changes and ratings updates: 2/3/2025 – Eli Lilly and Company had its price target raised by analysts at Truist ...
Citigroup Issues Pessimistic Forecast for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its target price lowered by equities researchers at Citigroup from ...
Aristotle Atlantic Focus Growth Strategy Increased its Holdings in Eli Lilly and Company (LLY)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2024 investor ...
clinicaltrialsarena14h
Lilly’s investigational Alzheimer’s to be investigated in prevention trial
The Washington University trial comes as part of a larger platform study which hopes to understand if Alzheimer's disease can ...
Pharmaceutical Technology5d
Top 20 biopharma companies’ market caps rise 1.7% over 2024 amid policy
The top 20 biopharmaceutical companies experienced mixed performance in 2024 amid a dynamic landscape influenced by various ...
Livewire Markets on MSN6d
ResMed's latest earnings are "super impressive", says this fund manager
Although RMD has re-rated from its share price low of around $21.50 in October 2023, it has only just surpassed its all-time ...
Competitive Intelligence in Breast Cancer: Tracking the Evolving HR+ HER2-ve Breast Cancer Landscape
A global pharmaceutical company partnered with DelveInsight to create a robust and simplified solution enabling its top ...
Pharmaceutical Technology20h
Radiopharmaceutical deals drive sector growth despite supply crisis
Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.